{
    "2021-05-04": [
        [
            {
                "time": "",
                "original_text": "摩根大通增持药明康德(02359)约93.38万股，每股作价约181.11港元",
                "features": {
                    "keywords": [
                        "摩根大通",
                        "增持",
                        "药明康德",
                        "港股"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "【行情】港股医药股终止连日涨势，复星医药跌3.9%，康龙化成跌3.6%，药明生物跌2.6%，药明康德跌2.2%，君实生物跌1.5%",
                "features": {
                    "keywords": [
                        "港股",
                        "医药股",
                        "下跌",
                        "复星医药",
                        "康龙化成",
                        "药明生物",
                        "药明康德",
                        "君实生物"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "2020年CDMO领域收入排行，五年内“药明生物”市占率必降 盈利能力下降",
                "features": {
                    "keywords": [
                        "CDMO",
                        "药明生物",
                        "市占率",
                        "盈利能力",
                        "下降"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "下一个“药明康德”来了？",
                "features": {
                    "keywords": [
                        "药明康德"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "1300亿美元怎么分？比尔·盖茨宣布与妻子离婚！5月券商金股出炉，4股业绩翻倍获机构扎堆推荐",
                "features": {
                    "keywords": [
                        "比尔·盖茨",
                        "离婚",
                        "券商金股",
                        "业绩翻倍",
                        "机构推荐"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}